The type of medication that will be used to treat MS will depend on the stage of MS, relapsing-remitting vs. progressive treatments. The differences between the two types of drugs are based on the fact that the relapsing patients are just trying to prevent their immune system from attacking the brain; whereas, the progressive patients are just trying to manage their resulting symptoms.
I have decided to research the relapsing-remitting drugs available because that is where the most current pharmacology research is being done and clinically tried. The more common and FDA approved relapsing-remitting drugs are known as Avonex, Betaseron, Copaxone, Novantrone, Rebif, and Tysabri.
I have decided to research the relapsing-remitting drugs available because that is where the most current pharmacology research is being done and clinically tried. The more common and FDA approved relapsing-remitting drugs are known as Avonex, Betaseron, Copaxone, Novantrone, Rebif, and Tysabri.
